Akebia Therapeutics

AKBA

14.99

-0.03

-0.2%

After Hours:

14.99

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 14.79
Prev. Close: 15.02
Low/Hi: 14.79 - 15.26
52-Week: 7.16 - 16.54
Volumes
Equity: 263,008
90-Day Avg: 798,980
Option: 99
90-Day Avg: 282
Volatility
Todays Stock Vol: 43.5
20-Day (HV): 46.1
52-Week (HV): 44.1
30-Day IV: 46.1 +8.5
IV Pct Rank: 26% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 9-Nov (Est.)
P/E Ratio:
Market Cap: 708.2 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AKBA Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 125,390 87,250 187,335 65,830
Short Term Investments 195,825 164,555 73,008 95,492
Investments - - - -
Accounts Receivable 0 0 33,823 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 11,174 3,248 2,155 3,825
Net Property Plant and Equipment 2,934 2,904 2,612 2,688
Other Current Assets 0 0 0 0
Current Assets 332,389 255,053 296,321 165,147
Goodwill and Intangibles 0 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 336,822 259,256 300,216 169,118
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,499 1,299 1,283 1,283
Accounts Payable 10,212 15,083 2,039 8,524
Accrued Liabilities and Other Payables 28,851 34,272 30,261 17,615
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 279,824 228,639 232,096 68,408
Other Current Liabilities 142,528 84,108 81,968 0
Accumulated Other Comprehensive Income -254 -179 -42 -7
Preferred Stock 0 0 0 0
Current Liabilities 181,591 133,463 114,268 26,139
Common Stock 0 0 0 0
Other Non-Current Liabilities 98,233 95,176 117,828 42,269
Additional Paid-In Capital 420,448 372,475 365,298 359,991
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -363,196 -341,679 -297,136 -259,274
Total Equity 56,998 30,617 68,120 100,710
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 187,335 49,778 32,780 21,215
Short Term Investments 73,008 88,676 76,138 11,341
Investments - - - -
Accounts Receivable 33,823 0 48 135
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 2,155 2,563 1,514 739
Net Property Plant and Equipment 2,612 540 210 30
Other Current Assets 0 0 0 0
Current Assets 296,321 141,017 110,480 33,431
Goodwill and Intangibles 0 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 300,216 142,940 110,995 34,665
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,283 1,383 305 1,203
Accounts Payable 2,039 2,313 2,021 714
Accrued Liabilities and Other Payables 30,261 9,555 4,864 3,184
Long Term Debt 0 0 0 8
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 4
Total Liabilities 232,096 11,942 6,917 3,910
Other Current Liabilities 81,968 0 0 0
Accumulated Other Comprehensive Income -42 -234 -56 0
Preferred Stock 0 0 0 157,827
Current Liabilities 114,268 11,868 6,885 3,902
Common Stock 0 0 0 0
Other Non-Current Liabilities 117,828 74 32 0
Additional Paid-In Capital 365,298 292,783 204,969 0
Treasury Stock 0 -162 -162 0
Other Equity 0 0 0 0
Retained Earnings -297,136 -161,389 -100,673 -127,072
Total Equity 68,120 130,998 104,078 30,755